These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 652142)

  • 1. On the central anti-serotoninergic actions of cyproheptadine and methysergide.
    Jacoby JH; Poulakos JJ; Bryce GF
    Neuropharmacology; 1978; 17(4-5):299-306. PubMed ID: 652142
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin neuroleptics change patterns of preovulatory secretion of luteinizing hormone in rats.
    Walker RF
    Life Sci; 1980 Sep; 27(12):1063-8. PubMed ID: 7191463
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo evidence of partial agonist activity exerted by purported 5-hydroxytryptamine antagonists.
    Colpaert FC; Niemegeers CJ; Janssen PA
    Eur J Pharmacol; 1979 Oct; 58(4):505-9. PubMed ID: 510385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A serotoninergic mechanism for the control of insulin secretion.
    Feldman JM; Levovitz HE
    Trans Assoc Am Physicians; 1972; 85():279-94. PubMed ID: 4267099
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats.
    Fuller RW; Snoddy HD
    Endocrinology; 1979 Oct; 105(4):923-8. PubMed ID: 477605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male rat.
    Krulich L; Vijayan E; Coppings RJ; Giachetti A; McCann SM; Mayfield MA
    Endocrinology; 1979 Jul; 105(1):276-83. PubMed ID: 446410
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotoninergic inhibition of LH secretion in the domestic fowl.
    Hall TR; Cheung A; Harvey S
    J Endocrinol; 1986 Aug; 110(2):239-44. PubMed ID: 2943849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative feedback control of serotonin release in vivo: comparison of 5-hydroxyindolacetic acid levels measured by voltammetry in conscious rats and by biochemical techniques.
    Baumann PA; Waldmeier PC
    Neuroscience; 1984 Jan; 11(1):195-204. PubMed ID: 6200799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ACTH, benzodiazepines and 5-HT antagonists on escape from periaqueductal grey stimulation in the rat.
    Clarke A; File SE
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(1):27-35. PubMed ID: 6180456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced changes of brain serotoninergic tone and insulin-induced growth hormone release in the dog.
    Locatelli V; Panerai AE; Cocchi D; Gil-Ad I; Mantegazza P; Secchi C; Müller EE
    Neuroendocrinology; 1978; 25(2):84-104. PubMed ID: 652121
    [No Abstract]   [Full Text] [Related]  

  • 11. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hypoglycemia-induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide.
    Bivens CH; Lebovitz HE; Feldman JM
    N Engl J Med; 1973 Aug; 289(5):236-9. PubMed ID: 4713762
    [No Abstract]   [Full Text] [Related]  

  • 13. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
    Langlais PJ; Gabay S
    J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of lysergic acid diethylamide, methysergide, and cyproheptadine on modality-specific and nonspecific sensory evoked potentials.
    Wilkison DM; Hosko MJ
    Exp Neurol; 1983 Nov; 82(2):391-403. PubMed ID: 6628626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of methysergide on 5-hydroxytryptamine turnover in whole brain.
    D'amico DJ; Patel BC; Klawans HL
    J Pharm Pharmacol; 1976 May; 28(5):454-6. PubMed ID: 6761
    [No Abstract]   [Full Text] [Related]  

  • 16. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral syndrome induced by allylnitrile, crotononitrile or 2-pentenenitrile in rats.
    Tanii H; Hayashi M; Hashimoto K
    Neuropharmacology; 1991 Aug; 30(8):887-92. PubMed ID: 1723510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of cyproheptadine, methysergide, BC 105 and reserpine on brain 5-hydroxytryptamine and brain growth.
    Hole K
    Eur J Pharmacol; 1972 Aug; 19(2):156-9. PubMed ID: 5071787
    [No Abstract]   [Full Text] [Related]  

  • 19. Modifications of the sexual activity in male rats following administration of antiserotoninergic drugs.
    Menéndez Abraham E; Morán Viesca P; Velasco Plaza A; Marín B
    Behav Brain Res; 1988 Oct; 30(3):251-8. PubMed ID: 3178996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Action of UML on levels of 5HT and 5HIAA in the rat brain with MAO blocking].
    Torre M; Torre E; Bogetto F
    Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1876-9. PubMed ID: 1027452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.